Cannabis & Biotech Advancers Forging Ahead - Company Contracts With One of The Oldest Marijuana Dispensaries in California
CORAL SPRINGS, Florida, March 10, 2014 /PRNewswire/ --
Biotech news and Marijuana's continued rise in growing demand results in companies taking steps to advantage of strategic alliances: OSL Holdings, Inc. (OTC: OSLH), Terra Tech Corp. (OTC: TRTC), Growlife, Inc. (OTCBB: PHOT), Medical Marijuana, Inc. (OTC: MJNA) and InterMune, Inc. (NASDAQ: ITMN).
OSL Holdings (OTCQB: OSLH) announced today its entry into the legal marijuana market. OSL Holdings has contracted with one of the oldest legal medical marijuana dispensaries in California, The Natural Way of LA, to develop marijuana production facilities in California. OSL intends to form a separate subsidiary to create production facilities in states that presently have legal medical marijuana dispensaries and also position itself to accommodate the growing recreational markets in Colorado and Washington and elsewhere as legal recreational markets emerge. OSL intends to spin off that subsidiary to its existing shareholders after complying with necessary SEC filings and procedures.
To read the entire press release, please go tohttp://www.fnmprofiles.com/profiles-oslh.html
In addition, The Natural Way of LA has executed a marketing agreement with the Equality Rewards division of OSL committing to participate in Equality Rewards.
Steve Gormley, President of Equality Rewards, said, "We are excited to extend Equality Rewards into the legal medical marijuana market in California. We look forward to participating in the "Green Rush" that is sweeping the nation and are positioned to support the legal recreational markets as they emerge."
Terra Tech Corp. (OTCQB: TRTC) through their subsidiary GrowOp Technology, is pleased to announce the formation of a team that will focus on medical cannabis opportunities in the Northeast. The team will be headed by Evan Nison, the Executive Director of NORML New Jersey and Co-Founder and Director of New York Cannabis Alliance. Evan, whose medical cannabis industry beginnings stem from the grassroots movement to tax and regulate initiatives, has been a driving force behind marijuana law reform in both New Jersey and New York. He brings years of experience and success running organizations focused on advocating on behalf of consumers, patients, business owners, and other stakeholders to progress sensible and responsible cannabis reform legislation.
Growlife, Inc. (OTCQB: PHOT) a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services of legal cannabis, is pleased to announce the completion of its first GIFT transaction with CMMS, Inc., known better in the Colorado mountain ski communities as LEAF Aspen and Fat City Test Kitchen. The GrowLife Infrastructure Funding and Technology program (GIFT) allows fully-licensed and compliant growers and dispensaries in well-regulated cannabis markets to spread the cost of infrastructure builds over time. The GIFT program is intended to facilitate near term infrastructure needs paired with long term exclusive supply relationships for the expendables required by fully licensed growers and dispensaries.
Medical Marijuana, Inc. (OTCPink: MJNA) HempMedsPX(TM) -- a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc. -- is continuing the Company's initiative to increase the public's awareness of their cannabidiol (CBD)-rich industrial hemp oil products at Natural Products Expo West March 7-9, 2014. Expo West hosts an estimated 60,000 attendees and HempMedsPX(TM) will exhibit the world's first line of CBD-rich hemp oil products from booth #1009. To further increase traffic among retailers and wholesalers who are interested in the CBD-rich hemp oil products that HempMedsPX(TM) represents, the Company is co-sponsoring Vitamin Retailer Magazine's "20-20 Scavenger Hunt Contest" in honor of the publication's 20th anniversary. Registered attendees must visit Vitamin Retailer Magazine's exhibit # 1209 at "Expo West" for a list of twenty exhibitors to visit -- including HempMedsPX's booth, #1009 -- in order to qualify for a wide range of prizes. Complete instructions can be found at Vitamin Retailer Magazine's exhibit booth.
InterMune, Inc. (NASDAQ: ITMN) recently announced that top-line data from ASCEND, a Phase 3 trial evaluating pirfenidone in patients with idiopathic pulmonary fibrosis (IPF), demonstrated that pirfenidone significantly reduced IPF disease progression as measured by change in percent predicted forced vital capacity (FVC) from Baseline to Week 52. "We are pleased to report these top-line ASCEND Phase 3 results," said Dan Welch, Chairman, Chief Executive Officer and President of InterMune. "Based on the strength of the ASCEND results, InterMune is preparing a resubmission of our New Drug Application for pirfenidone to the U.S. Food and Drug Administration (FDA), which we expect to submit by early third quarter of this year. We would like to thank our collaborators, patients and their families for their participation in ASCEND and their contributions to IPF research."
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand seven hundred dollars for news coverage of the current press release issued by OSL Holdings, Inc. by the company.
FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
SOURCE FN Media Group, LLC